In the context of GBM, CEBPB not only governs the proliferation, migration, and invasion of glioma cells 57, but it is also closely linked with the MES subtype of GBM, correlating with unfavorable clinical outcomes 58. This evidence concerns the gene CEBPB and central nervous system cancer.